(Q43540807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients' perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

R Yuval

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Uziel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N Gordon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Merdler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N Khader

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Karkabi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Y Flugelman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B S Lewis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

217-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11246060%20AND%20SRC:MED&resulttype=core&format=json

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Digoxin therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Placebo Treatment in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Clinical trials: specific problems associated with the use of a placebo control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Powerful placebo: the dark side of the randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Factors affecting quality of informed consent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Informed consent: study of quality of information given to participants in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Placebo effect in double-blind clinical trials: a review of interactions with medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3

Risk factors for the development of placebo adverse reactions in a multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900151-3